resveratrol has been researched along with Absence Status in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 5 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, NC; Chen, SD; Chen, SF; Chuang, YC; Hsu, CY; Jou, SB | 1 |
| Hattiangady, B; Kodali, M; Mishra, V; Rao, X; Shetty, AK; Shetty, GA; Shuai, B | 1 |
| Shetty, AK | 1 |
| Friedman, LK; Friedman, S; Goldstein, B; Rafiuddin, A; Roblejo, P | 1 |
| Bo, QY; Chi, ZF; Liu, XW; Wang, SJ; Yang, X; Zhao, XH | 1 |
1 review(s) available for resveratrol and Absence Status
| Article | Year |
|---|---|
Promise of resveratrol for easing status epilepticus and epilepsy.
Topics: Animals; Epilepsy; Hippocampus; Humans; Resveratrol; Seizures; Status Epilepticus; Stilbenes | 2011 |
4 other study(ies) available for resveratrol and Absence Status
| Article | Year |
|---|---|
Resveratrol Promotes Mitochondrial Biogenesis and Protects against Seizure-Induced Neuronal Cell Damage in the Hippocampus Following Status Epilepticus by Activation of the PGC-1α Signaling Pathway.
Topics: Animals; Disease Models, Animal; Hippocampus; Male; Mitochondria; Neurons; Neuroprotective Agents; Organelle Biogenesis; Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha; Rats; Rats, Sprague-Dawley; Resveratrol; Status Epilepticus | 2019 |
Resveratrol Treatment after Status Epilepticus Restrains Neurodegeneration and Abnormal Neurogenesis with Suppression of Oxidative Stress and Inflammation.
Topics: Animals; Behavior, Animal; Cell Adhesion Molecules, Neuronal; Cell Death; Cognition; Extracellular Matrix Proteins; GABAergic Neurons; Gene Expression Regulation; Hippocampus; Inflammation; Interneurons; Longevity; Male; Microglia; Nerve Degeneration; Nerve Tissue Proteins; Neurogenesis; Neuropeptide Y; Oxidative Stress; Parvalbumins; Rats, Inbred F344; Reelin Protein; Resveratrol; Seizures; Serine Endopeptidases; Somatostatin; Status Epilepticus; Stilbenes; Tumor Necrosis Factor-alpha | 2015 |
Lack of resveratrol neuroprotection in developing rats treated with kainic acid.
Topics: Age Factors; Analysis of Variance; Animals; Animals, Newborn; Body Weight; Brain Waves; Cell Count; Disease Models, Animal; Electroencephalography; Excitatory Amino Acid Agonists; Female; Gene Expression Regulation, Developmental; Hippocampus; Kainic Acid; Lipid Peroxidation; Male; Malondialdehyde; Neuroprotective Agents; Phosphopyruvate Hydratase; Rats; Rats, Sprague-Dawley; Receptors, N-Methyl-D-Aspartate; Resveratrol; Status Epilepticus; Stilbenes | 2013 |
Resveratrol pre-treatment reduces early inflammatory responses induced by status epilepticus via mTOR signaling.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Blotting, Western; Electrophoretic Mobility Shift Assay; Enzyme-Linked Immunosorbent Assay; Hippocampus; Inflammation; Male; Rats; Rats, Wistar; Real-Time Polymerase Chain Reaction; Resveratrol; Reverse Transcriptase Polymerase Chain Reaction; Signal Transduction; Status Epilepticus; Stilbenes; TOR Serine-Threonine Kinases | 2013 |